Anda di halaman 1dari 47

Copyright 2004 Eli Lilly and Company

Docking & Scoring


EMBO-Course: Methods for Protein Simulation & Drug
Design. Shanghai, China, September 13-24, 2004.
Qi Chen
Eli Lilly & Company
Indianapolis, Indiana
U.S.A.
qchen@lilly.com
September 21, 2004
Copyright 2004 Eli Lilly and Company 2
Outline
Introduction
Docking Methods
Representation of receptor binding site and ligand
Sampling of configuration space of the ligand-receptor complex
Scoring Methods
Free energy, binding affinity, and docking scores
Scoring functions, consensus scoring, and others
Docking Software
Existing software
DOCK, FlexX, GOLD, AutoDock, LUDI, Glide, FRED, CDOCKER
Accuracy, Applications, and Successes
September 21, 2004
Copyright 2004 Eli Lilly and Company 3
What Are Docking & Scoring?
To place a ligand (small molecule) into the binding site of a
receptor in the manners appropriate for optimal interactions
with a receptor.
To evaluate the ligand-receptor interactions in a way that may
discriminate the experimentally observed mode from others
and estimate the binding affinity.
ligand
receptor
complex
docking scoring
etc
X-ray structure
& AG
September 21, 2004
Copyright 2004 Eli Lilly and Company 4
Why Do We Do Docking?
Drug discovery costs are too high: ~$800 millions, 8~14 years,
~10,000 compounds (DiMasi et al. 2003; Dickson & Gagnon
2004)
Drugs interact with their receptors in a highly specific and
complementary manner.
Core of the target-based structure-based drug design (SBDD)
for lead generation and optimization.
Lead is a compound that
shows biological activity,
is novel, and
has the potential of being structurally modified for improved bioactivity,
selectivity, and drugeability.
September 21, 2004
Copyright 2004 Eli Lilly and Company 5
Three Components of Docking
Representation of receptor
binding site and ligand
pre- and/or
during docking:
Sampling of configuration space
of the ligand-receptor complex
during docking:
Evaluation of ligand-receptor
interactions
during docking
and scoring:
September 21, 2004
Copyright 2004 Eli Lilly and Company 6
Receptor Structures & Binding Site
Descriptions
PDB (Protein Data Bank, www.rcsb.org/pdb/) containing proteins or
enzymes:
X-ray crystal: >12,000 structures, 788 have 1.5 , 9,390 between 1.5-2.5
NMR: >450 structures, ensemble accuracy of 0.4-1 in the backbone region, 1.5
in average side chain position (Billeter 1992; Clore et al. 1993)
(and high quality homology models built from highly similar sequences)
Limitation of experimental structures (Davis et al. 2003):
Locations of hydrogen atoms, water molecules, and metal ions
Identities and locations of some heavy atoms (e.g., ~1/6 of N/O of Asn & Gln, and
N/C of His incorrectly assigned in PDB; up to 0.5 uncertainty in position)
Conformational flexibility of proteins
Binding site descriptions: atomic coordinates, surface,
volume, points & distances, bond vectors, grid and
various properties such as electrostatic potential,
hydrophobic moment, polar, nonpolar, atom types, etc.
DOCK
September 21, 2004
Copyright 2004 Eli Lilly and Company 7
Drug, Chemical & Structural Space
Drug-like: MDDR (MDL Drug Data Report) >147,000 entries, CMC (Comprehensive
Medicinal Chemistry) >8,600 entries
Non-drug-like: ACD (Available Chemicals Directory) ~3 million entries
Literatures and databases, Beilstein (>8 million compounds), CAS & SciFinder
CSD (Cambridge Structural Database, www.ccdc.cam.ac.uk): ~3 million X-ray crystal
structures for >264,000 different compounds and >128,00 organic structures
Available compounds
Available without exclusivity: various vendors (& ACD)
Available with limited exclusivity: Maybridge, Array, ChemDiv, WuXi Pharma,
ChemExplorer, etc.
Corporate databases: a few millions in large pharma companies
September 21, 2004
Copyright 2004 Eli Lilly and Company 8
3D Structural Information & Ligand
Descriptions
2D->3D software: CORINA, OMEGA, CONCORD, MM2/3,
WIZARD, COBRA. (reviewed by Robertson et al. 2001)
CSD: <0.1 for small molecules, but may not be the bound
conformation in the receptor
PDB: ligand-bound protein structures ~6000 entries
Atoms associated with inter-atom distances, physical and
chemical properties, types, charges, pharmacophore, etc
Flexibility: conformation ensemble, fragment-based
September 21, 2004
Copyright 2004 Eli Lilly and Company 9
Sampling of Configuration Space of
The Ligand-Receptor Complex
Descriptor-matching: using pattern-recognizing geometric methods to
match ligand and receptor site descriptors
geometric, chemical, pharmacophore properties, such as distance pairs, triplet,
volume, vector, hydrogen-bond, hydrophobic, charged, etc.
Molecular simulation: MD (molecular dynamics), MC (Monte Carlo)
Others: GA (genetic algorithm), similarity, fragment-based
Challenges
Complete conformation and configuration space of ligand and receptor complex
are too large.
Conformational flexibility of both ligand and receptor cant be ignored.
Shape-matching: No best method and general solutions for describing and
matching molecular shape of irregular objects (Ullman 1976; Salomaa 1991).
Shape alone is not sufficient descriptor to identify low-energy conformations of a
ligand-receptor complex (Jorgensen 1991).
September 21, 2004
Copyright 2004 Eli Lilly and Company 10
Descriptor Matching Methods: DOCK
Distance-compatibility graph in DOCK (Ewing and Kuntz 1997): distances
between sphere centers and distances between ligand heavy atoms
September 21, 2004
Copyright 2004 Eli Lilly and Company 11
Descriptor Matching Methods
Distance-compatibility graph in DOCK (Ewing and Kuntz 1997): distances
between sphere centers and distances between ligand heavy atoms
Interaction site matching in LUDI (Boehm 1992): HBA<->HBD, HYP<->HYP
Pose clustering and triplet matching in FlexX (Rarey et al. 1996): HBA<-
>HBD, HYP<->HYP
Shape-matching in FRED (Openeye www.eyesopen.com)
Vector matching in CAVEAT (Lauri and Bartlett 1994)
Steric effects-matching in CLIX (Lawrence and Davis 1992)
Shape chemical complementarity in SANDOCK (Burkhard et al. 1998)
Surface complementarity in LIGIN: (Sobolev et al. 1996)
H-bond matching in ADAM (Mizutani et al. 1994)
September 21, 2004
Copyright 2004 Eli Lilly and Company 12
Fragment-based Methods
Flexibility and/or de novo design
Identification and placement of the base/anchor fragment are very important
Energy optimization (during or post-docking) is important
Examples
Incremental construction in FlexX with triplet matching and pose clustering to maximize the
number of favorable interactions
Growing and/or joining in LUDI from pre-built fragment and linker libraries and maximize H-
bond and hydrophobic interactions
Anchor-based fragment joining in DOCK
September 21, 2004
Copyright 2004 Eli Lilly and Company 13
Molecular Simulation: MD & MC
Two major components:
The description of the degrees of freedom
The energy evaluation
The local movement of the atoms is performed
Due to the forces present at each step in MD (Molecular Dynamics)
Randomly in MC (Monte Carlo)
Usually time consuming:
Search from a starting orientation to low-energy configuration
Several simulations with different starting orientation must be performed to get a
statistically significant result
Grid for energy calculation. Larger steps or multiple starting poses
are often used for speed and sampling coverage in MD:
Di Nola et al. 1994; Mangoni et al. 1999; Pak & Wang 2000; CDOCKER by Wu et
al. 2003.
September 21, 2004
Copyright 2004 Eli Lilly and Company 14
MC-based Docking
where T is reduced based on a so-called cooling schedule, and grid can be used for
energy calculation.
An advantage of the MC technique compared with gradient-based
methods (e.g. MD) is that a simple energy function can be used
which does not require derivative information, and able to step over
energy barrier.
AutoDOCK (Goodsell & Olson 1990). MCDOCK (Liu & Wang 1999),
PRODOCK (Trosset & Scheraga 1999), ICM (Abagyan et al. 1994).
Simulated annealing is used in DockVision (Hart & Read 1992) and
Affinity (Accelrys Inc., San Diego, CA)
Energy minimization is used in QXP (McMartin & Bohacek 1997).
|
|
.
|

\
|

=
T k
A E B E
P
B
) ( ) (
exp
September 21, 2004
Copyright 2004 Eli Lilly and Company 15
Genetic Algorithm Docking
A fitness function is used to decide which individuals (configurations)
survive and produce offspring for the next iteration of optimization.
Degrees of freedom are encoded into genes or binary strings.
The collection of genes (chromosome) is assigned a fitness based
on a scoring function. There are three genetic operators:
mutation operator randomly changes the value of a gene;
crossover exchanges a set of genes from one parent chromosome to another;
migration moves individual genes from one sub-population to another.
Requires the generation of an initial population where conventional
MC and MD require a single starting structure in their standard
implementation.
GOLD (Jones et al. 1997); AutoDock 3.0 (Morris et al. 1998); DIVALI
(Clark & Ajay 1995).
September 21, 2004
Copyright 2004 Eli Lilly and Company 16
Multiple Method Approach
Similarity-guided MD simulated annealing to improve accuracy
(Wu & Vieth 2004).
Shape similarity & clustering to speed up conformational
search in docking (Makino & Kuntz 1998).
Better input or constrains for the existing docking engines
systematic search
conformations
rigid DOCK
minimization
MD/SA
(Wang et al. 1999)

initial poses
filters
finer docking final scoring
(FRED, GLIDE, DOCK)
September 21, 2004
Copyright 2004 Eli Lilly and Company 17
Scoring Functions
A fast and simplified estimation of binding energies

( )
A + A A + A A A =
= A
S T G G G G
K RT G
n interactio solv protein solv ligand solv complex
affinity binding
/ / /
ln
configurations of the complex
-
s
c
o
r
e
s

X-ray
structure
?
scores <-> AG
binding
September 21, 2004
Copyright 2004 Eli Lilly and Company 18
Types of Scoring Functions
Force field based: nonbonded interaction terms as the score,
sometimes in combination with solvation terms
Empirical: multivariate regression methods to fit coefficients of physically
motivated structural functions by using a training set of ligand-receptor
complexes with measured binding affinity
Knowledge-based: statistical atom pair potentials derived from
structural databases as the score
Other: scores and/or filters based on chemical properties,
pharmacophore, contact, shape complementary
Consensus scoring functions approach
September 21, 2004
Copyright 2004 Eli Lilly and Company 19
Force Field Based Scoring Functions
Advantages
FF terms are well studied and have some physical basis
Transferable, and fast when used on a pre-computed grid
Disadvantages
Only parts of the relevant energies, i.e., potential energies & sometimes
enhanced by solvation or entropy terms
Electrostatics often overestimated, leading to systematic problems in
ranking complexes

= =
|
|
.
|

\
|
+ =
lig
i
rec
j
ij
j i
b
ij
ij
a
ij
ij
Dr
q q
r
B
r
A
E
1 1
332
e.g. AMBER FF in DOCK
September 21, 2004
Copyright 2004 Eli Lilly and Company 20
FF Scoring: Implementations
AMBER FF: DOCK, FLOG, AutoDOCK
CHARMm FF: CDOCK, MC-approach (Caflisch et al. 1997)
Potential Grid: rigid receptor structure upon docking. The grid-based score
interpolates from eight surrounding grid points only. 100-fold speed up. Examples:
DOCK, CDOCK, and many other docking programs.
Soften VDW: A soft-core vdw potential is needed for the kinetic accessibility of the
binding site (Vieth et al. 1998). FLOG: 6-9 Lennard-Jones function; GOLD: 4-8 vdw +
H-bond, and intraligand energy.
Solvent Effect on Electrostatic: often approximated by rescaling the in vacuo
coulomb interactions by 1/D, where D = 1-80 or = n*r, n = 1-4, r = distance.
Solvation and Entropy Terms: Solvation terms decomposed into nonpolar and
electrostatic contributions (e.g., DOCK):
np solv elec solv nonbond bind
E E E E
, ,
=
September 21, 2004
Copyright 2004 Eli Lilly and Company 21
Empirical Scoring Functions
Goals: reproduce the experimental values of binding energies and with its global
minimum directed to the X-ray crystal structure
Advantages: fast & direct estimation of binding affinity
Disadvantages
Only a few complexes with both accurate structures & binding energies known
Discrepancy in the binding affinities measured from different labs
Heavy dependence on the placement of hydrogen atoms
Heavy dependence of transferability on the training set
No effective penalty term for bad structures
( )
( ) ( )
( ) o
o o
o
A A A +
A A A + A A A +
A A A + A + A = A



, .
, int _ , int _
, _
0
R f cont lipo G
R f aro G R f ionic G
R f Hbonds neutral G N G G G
lipo
aro io
HB rot rot
LUDI & FlexX
(Boehm 1994)
September 21, 2004
Copyright 2004 Eli Lilly and Company 22
Empirical Scoring: Implementations
Mostly differ by what training set and how many parameters are used
Cerius2/Insight2000: LUDI, ChemScore, PLP, LigScore
SYBYL: FlexX, F-Score
Hammerhead: 17 parameters for hydrophobic, polar complementary, entropy,
solvation. s
LOO
= 1.0 logK for 34 complexes
VALIDATE: 8 parameters for VDW and Coulomb interactions, surface
complementarity, lipophilicity, conformational entropy and enthalpy, lipophilic and
hydrophilic complementarity between receptor and ligand surfaces
PRO_LEADS: 5 coefficients for lipophilic, metal-binding, H-bond, and a flexibility
penalty term. s
LOO
= 2 kcal/mol for 82 complexes
SCORE (Tao & Lai, 2001); ChemScore (GOLD)
September 21, 2004
Copyright 2004 Eli Lilly and Company 23
Knowledge-based Potentials of Mean
Force Scoring Functions (PMF)
Assumptions
An observed crystallographic complex represents the optimum placement of the
ligand atoms relative to the receptor atoms
The Boltzmann hypothesis converts the frequencies of finding atom A of the ligand
at a distance r from atom B of the receptor into an effective interaction energy
between A and B as a function of r
Advantages
Similar to empirical, but more general (much more distance data than binding
energy data)
Disadvantages
The Boltzmann hypothesis originates from the statistics of a spatially uniform
liquid, while receptor-ligand complex is a two-component non-uniform medium
PMF are typically pair-wise, while the probability to find atoms A and B at a
distance r is non-pairwise and depends also on surrounding atoms
September 21, 2004
Copyright 2004 Eli Lilly and Company 24
PMF: Implementations
Verkhivker et al.(1995): 12 atom pairs, 30 complexes (HIV-1 and simian
immunodeficiency virus). Test on 7 other HIV-1 protease complexes
Wallqvist et al. (1995): 38 complexes, 21 atom types (10 C, 5 O, 5 N,
1 S). Test on 8 complexes sd=1.5 kcal/mol, and 20 complexes rmsd=1.0 A.

Muegge et al. (1999): 697 complexes, 16 atom types from receptor &
34 from ligand, 282 statistically significant PMF interactions. Test on 77
diverse compounds: sd=1.8 log Ki. The PMF was combined with a vdw term to
account for short-range interactions for DOCK4 docking:


DrugScore (Gohlke et al, 2000), FlexX, BLEEP
( )

+ + = A
i j
ij ij pred
P G | o o ln
( )

<
=
ij
cutoff
r r kl
ij
r A score PMF
,
_ ( ) ( )
( )
(
(

=
ij
bulk
ij
seg
j
corr Vol B ij
r
r f T k r A

_
ln
where
September 21, 2004
Copyright 2004 Eli Lilly and Company 25
Consensus Scoring and Others
Too many scoring functions, none prevails in terms of predictivity
Combined approach: one scoring function to sample configuration
space, the other(s) to optimize and/or score:
2 docking methods & 13 scoring functions to significantly reduces false positive
rate (Charifson et al. 1999)
Postprocessing of docking results with a filter function followed by re-scoring
(Stahl & Bohm 1998)
ADAM, FlexX, Hammerhead
SYBYL Cscore (Tripos) : FlexX, PMF, DOCK energy, GOLD score
C2 (Accelrys) : LigScore2, PLP, PMF, Ludi, Jain
FRED (OpenEye) : ChemScore, PB-SA, ChemGauss, PLP, ScreenScore
DOCK: AMBER FF, PMF, contact scores, ChemScore
Reduce false positives!
September 21, 2004
Copyright 2004 Eli Lilly and Company 26
An Example of Combined Empirical and
Knowledge-based Approach
Procedure
1. Knowledge-based potentials
2. Optimize the ligand position with the scoring function
3. Fit the scores to experimental values
4. Re-optimize ligand positions iteratively until the ligand positions and calibrated
parameters have finally converged.
Scoring function: 7 atom types (1 C, 4 O, 2 N), cutoff 7 A, 2000 complexes,
rmsd<2A, no metal ions, 164 binding energies, sd =2.1 kcal/mol, rmsd=0.49A


Validation: 36 rigid complexes, AlgoDock, FlexX, Gold, Dock, rmsd 0.74-1.68A; 25
known binding energies: sd = 2.0 kcal/mol
)
) (
exp( ) (
,
,
T
r F
r P
B A
B A

C r P T r F
B A B A
+ = )) ( log( ) (
, ,
Muryshev et al. 2003

= A
j i
j i B A
r F G
,
, ,
) (
2
,
,
) (
) (
r
r n
r P
B A
B A
= &
September 21, 2004
Copyright 2004 Eli Lilly and Company 27
Docking Software
DOCK: (Kuntz et al. 1982)
DOCK 4.0 (Ewing & Kuntz 1997)
AutoDOCK (Goodsell & Olson 1990)
AutoDOCK 3.0 (Morris et al. 1998)
GOLD (Jones et al. 1997)
FlexX: (Rarey et al. 1996)
GLIDE: (Friesner et al. 2004)
ADAM (Mizutani et al. 1994)
CDOCKER (Wu et al. 2003)
CombiDOCK (Sun et al. 1998)
DIVALI (Clark & Ajay 1995)
DockVision (Hart & Read 1992)
FLOG (Miller et al. 1994)
GEMDOCK (Yang & Chen 2004)
Hammerhead (Welch et al. 1996)
LIBDOCK (Diller & Merz 2001)
MCDOCK (Liu & Wang 1999)
PRO_LEADS (Baxter et al. 1998)
SDOCKER (Wu et al. 2004)
QXP (McMartin & Bohacek 1997)
Validate (Head et al. 1996)
de novo design tools
LUDI (Boehm 1992),
BUILDER (Roe & Kuntz 1995)
SMOG (DeWitte et al. 1997)
CONCEPTS (Pearlman & Murcko 1996)
DLD/MCSS (Stultz & Karplus 2000)
Genstar (Rotstein & Murcko 1993)
Group-Build (Rotstein & Murcko 1993)
Grow (Moon & Howe 1991)
HOOK (Eisen et al. 1994)
Legend (Nishibata & Itai 1993)
MCDNLG (Gehlhaar et al. 1995)
SPROUT (Gillet et al. 1993)

September 21, 2004
Copyright 2004 Eli Lilly and Company 28
Docking Software: Important Factors
Sensitivity on and transferability of the parameters, including the
starting conformation
Adaptability to additional scoring functions, pre- and/or post- docking
processing and filters
Ability for iteratively refining docking parameter/protocol based on
new results
Design, components, and results of validation studies
Speed, user interface & control, I/O, structural file formats
User learning curve, customer supports, and cost
Code availability and upgrading possibility
September 21, 2004
Copyright 2004 Eli Lilly and Company 29
DOCK (Kuntz, UCSF)
Receptor Structure
X-ray crystal
NMR
homology
Binding Site
Molecular Surface
of Binding Site
Spheres describing the
shape of binding site and
favorable locations of
potential ligand atoms
Matching heavy atoms of
ligands to centers of
spheres to generate thousands
of binding orientations
Scoring Orientations
1. Energy scoring (vdw and electrostatic)
2. Contact scoring (shape complementarity)
3. Chemical scoring
4. Solvation terms
Virtual Screening for
MTS/HTS and Library
Design: ligands in the order
of their best scores
Binding Mode Analysis for
Lead Optimization: binding
orientations and scores for each
ligands
Ligands
3D structure
atomic charges
potentials
labeling
Filters
September 21, 2004
Copyright 2004 Eli Lilly and Company 30
DOCK: Conformational Flexibility
Torsion-drive and anchor-based options (DOCK4.0)
GA to generate ligand conformations inside the binding site (Oshiro
et al. 1995)
A ligand anchor fragment is selected and placed in the receptor,
followed by rigid body simplex minimization (Makino & Kuntz 1997)
Ensembles: ~300 conformations are created with the rigid part
superimposed. DOCK applied to the rigid part and all conformation
were tested for overlap and scored. (Lorber & Shoichet 1998)
Multiple random ligand conformations (Ewing et al. 2001)
Ensemble of protein structures (Knegtel et al. 1997)
September 21, 2004
Copyright 2004 Eli Lilly and Company 31
FlexX (Tripos/SYBYL)
Fragment-based, descriptor matching, empirical scoring (Rarey et al.
1996)
Procedures:
Select a small set of base fragment suitable for placement using a simple scoring
function.
Place base fragments with the pose clustering algorithm: rigid, triplet matching of
H-bond & hydrophobic interactions, Bohm's scoring function
Build up the remainder of the ligand incrementally from other fragments
Ligand conformations
MIMUMBA model with CSD derived low energy torsional angles for each rotatable
bond and ring from CORINA.
Multiple conformations for each fragment in the ligand building steps
Other works: Explicit waters are placed into binding site during the docking
procedure using pre-computed water positions(Rarey et al. 1999). Receptor flexibility
using discrete alternative protein conformations (Claussen et al. 2001; Claussen &
Hindle 2003)
September 21, 2004
Copyright 2004 Eli Lilly and Company 32
GOLD
GA method, H-bond matching, FF scoring (Jones et al. 1997)
A configuration is represented by two bit strings:
1. The conformation of the ligand and the protein defined by the torsions;
2. A mapping between H-bond partners in the protein and the ligand.
For fitness evaluation, a 3D structure is created from the chromosome
representation. The H-bond atoms are then superimposed to H-bond site points
in the receptor site.
Fitness (scoring) function: H-bond, the ligand internal energy, the protein-ligand
van der Waals energy
Rotational flexibility for selected receptor hydrogens along with full ligand
flexibility
Highlights:
Validation test set: 100 complexes, 66 with rmsd<2A.
The structure generation is biased towards inter-molecular H-bonds.
Hydrophobic fitting points was added (GOLD 1.2, CCDC, Cambridge, UK 2001).
September 21, 2004
Copyright 2004 Eli Lilly and Company 33
AutoDock & AutoDock 3.0
Early implementation: MC simulated annealing, AMBER FF-based
energy grid, flexible ligands (Goodsell & Olson 1990)
AutoDock 3.0: GA as a global optimizer combined with energy
minimization as a local search method, flexible ligand, rigid protein as
represented in a grid (Morris et al. 1998)
The fitness function:
a Lennard-Jones 12-6 dispersion/repulsion term
a directional 12-10 hydrogen bond term
a coulombic electrostatic potential
a term proportional to the number of sp3 bonds in the ligand to represent
unfavorable entropy of ligand binding
a desolvation term
September 21, 2004
Copyright 2004 Eli Lilly and Company 34
LUDI: Matching polar and hydrophobic groups
Calculate protein and ligand interaction sites (H-bond or
hydrophobic), which are defined by centers and surface, from
non-bonded contact distributions based on a search through the CSD,
a set of geometric rules,
the output from the program GRID (Goodford 1985) which calculates binding
energies for a given probe with a receptor molecule.
Fit fragments onto the interaction sites.
distance between interaction sites on the receptor
an RMSD superposition algorithm,
A hashing scheme to access and match surface triangles onto a triangle query of
a ligand interaction center.
A list-merging algorithm creates all triangles based on lists of fitting triangle edges
for two of the three query triangle edges.
Join/grow fragments using the databases of fragments and the same
fitting algorithm.
September 21, 2004
Copyright 2004 Eli Lilly and Company 35
GLIDE (www.schrodinger.com)
Funnel: site point search -> diameter test -> subset test -> greedy score ->
refinement -> grid-based energy optimization -> GlideScore.
Approximates a complete systematic search of the conformational,
orientational, and positional space of the docked ligand.
Hierarchical filters, including a rough scoring function that recognizes
hydrophobic and polar contacts, dramatically narrow the search space
Torsionally flexible energy optimization on an OPLS-AA nonbonded potential
grid for a few hundred surviving candidate poses.
The very best candidates are further refined via a MC sampling of pose
conformation.
A modified ChemScore (Eldridge et al. 1997) that combines empirical and
force-field-based terms.
Validation: 282 complexes, new ligand conformation, the top-ranked pose:
50%<1 A, ~33% >2 A.
September 21, 2004
Copyright 2004 Eli Lilly and Company 36
FRED (OpenEye www.eyesopen.com)
Systematic, nonstochastic, docking
Directed docking with SMARTS enclosures
ChemScore, PB-SA, ChemGauss, PLP, ScreenScore
Multiple active site comparisons
Multiple simultaneous scoring functions and hit lists
RMS clustering of hit-lists
Refinement of docked poses in the context of the active site using MMFF
On-the-fly OMEGA conformer generation
Robust reading and specification-compliant writing of SDF, MOL, MOL2,
PDB, MacroModel, XYZ, and OEBinary file formats
Distributed processing via PVM for most Unix platforms
September 21, 2004
Copyright 2004 Eli Lilly and Company 37
CDOCKER & SDOCKER
Randomly generate ligand seeds in the binding site
High temperature MD using a modified version of CHARMM
Locate minima from all of the MD simulations
Fully minimization
Cluster on position and geometry
Rank by energy (interaction + ligand conformation)
SDOCKER: X-ray structure of complex as templates to guide docking
Wu et al. 2003;
Wu et al. 2004.
September 21, 2004
Copyright 2004 Eli Lilly and Company 38
Matrix of Accuracy & Success
Drug <- Quality Novel Lead <- Active
Reproduce binding mode (X-ray crystal structures)
Predict binding affinity (free energies)
Rank diverse set of compounds (by binding affinity)
Enhance hit rate for database mining
Reduce false positive (N
selected
-N
hits
) and false negative (N
all_hits
-N
hits
)
Fast enough for iterative SBDD
0
_ 0
|
.
|

\
|
|
.
|

\
|
= =
all
hits all
VS
selected
hits
VS
N
N
N
N
H
H
EF
active inactive
active TRUE FALSE
inactive FALSE TRUE
September 21, 2004
Copyright 2004 Eli Lilly and Company 39
Accuracy of Docking
Reality Boundary
Experimental errors: 0.1-0.25 kcal/mol (18-53%) with MSR (maximum significant
ratio) as much as 3 fold (0.65 kcal/mol)
Free energy calculation accuracy: ~1 kcal/mol (5.4 fold) starting with an accurate
geometric model & fully sampling
Entropy and solvation estimation need a sufficiently long simulation run with an
accurate force field, an ensemble of explicit of water molecules, and fully sampling
Current
Reproduce X-ray structure with rmsd<2A: 50-90% achievable
Binding affinity: 1.5~2 log unit (32-100 fold, 2.05-2.73 kcal/mol)
Correlation between scores and affinities, r^2<0.3
Enthalpy ranking with minimization: 5 kcal/mol
Hit rate enhancement : 2~50 fold with hit rate 1-20% (and high false negative rate
if 1~5% of total compounds selected)
(Wang et al. 2003; Erickson et al. 2004; and others.)
September 21, 2004
Copyright 2004 Eli Lilly and Company 40
Docking Accuracy: Examples
Example 1. Docking of a focused library of 55 PI3Kg inhibitors which
share a common chemotype, IC50 8-20000 nM
GLIDE docking, scored by LUDI, Ligscore, GScore, PMF, PLP.
r^2=0.02-0.15
Straight GLIDE docking: hit rate 0.34%.
Used additional knowledge (only poses with substructures rmsd <2.5 A vs. a co-
crystal), hit rate 9.8% (J. Klicic, 2004)
1,000,000 tested 3,000 actives
10 quality
novel leads
0.3% 0.3%
1,500
actives
15,000 needed
if only 200-2,000 selected
10%, EF=33
75-100%, EF>250
Typical HTS
To find 5 quality leads using docking:
September 21, 2004
Copyright 2004 Eli Lilly and Company 41
Docking Accuracy: More Examples
Example 2. 800 PDB complexes, resolution<2.5A, Ki or Kd known,
MW<1000, non-covalent bond, no cofactor, 200 different proteins
13 scoring functions from SYBYL, Cerius2, GOLD, etc
r^2 = 0.02 to 0.32, sd = 1.8 to 2.2 log (2.5-3.0 kcal/mol)
Best from X-Score, DrugScore, Sybyl ChemScore, Cerius2 PLP (Wang et. al.
2004)
Example 3. Compared CDOCKER, DOCK, GOLD, FlexX for
reproducing X-ray crystal structure with rmsd < 2 A
The most important factors are flexibility of protein and ligand
Suggest to apply VS on only compounds with <8 rotatable bonds
Use CORINA for 3D conformation generation
Softer potentials in the beginning (Erickson et al. 2004)
Bottom line: current docking is almost always better than random, but
still way too inaccurate to be a sole or dominant approach for lead
generation. Multiple CADD & SBDD approaches should be used for
any VS/MTS and lead optimization efforts.
September 21, 2004
Copyright 2004 Eli Lilly and Company 42
Docking Applications
Determine the lowest free energy structures for the receptor-
ligand complex
Search database and rank hits for lead generation
Calculate the differential binding of a ligand to two different
macromolecular receptors
Study the geometry of a particular complex
Propose modification of a lead molecules to optimize potency
or other properties
de novo design for lead generation
Library design
September 21, 2004
Copyright 2004 Eli Lilly and Company 43
Docking of Combinatorial Libraries
Combinatorial docking problem: given a library of ligands, calculate
the docking score (and the geometry of the complex) for each molecules of
the library
R-group selection problem: given a library, select molecules for the
individual R-groups in order to form a smaller sublibrary with an enriched
number of hits
de novo library design: given a catalog of available reagents, design a
library (incl. The rules of synthesis) that will optimize the number of hits
The incremental construction method: PRO_SELECT, CombiDOCK
(Sun, Ewing et al. 1998), FlexXc
Docking of the fully enumerated library followed by plate
optimization or cherry-picking
September 21, 2004
Copyright 2004 Eli Lilly and Company 44
Docking to Nucleic Acid Targets
RNA and DNA as potential drug targets
Ribosome RNA structures (Agalarov et al. 2000; Ban et al. 2000; Filikov
et al. 2000; Nissen et al. 2000; Wimberly et al. 2000)
Highly charged environments, well-defined binding pocket
DOCK identified compounds selectively bind to RNA duplexes or
DNA qudraplexes (Chen et al. 1996; Chen et al. 1997). The portions
in the DOCK suite that calculate electrostatics, including solvation,
partial charges, and scoring function were recently optimized for
RNA targets (Downing et al. 2003; Kang et al. 2004).
A MC minimization and an empirical scoring function which accounts
for solvation, isomerization free energy, and changes in
conformational entropy were used to rank compounds (Hermann &
Westhof 1999).
September 21, 2004
Copyright 2004 Eli Lilly and Company 45
Challenges to Docking Approach
Binding affinity is only one of many attributes of a drug
Structures of most drugeable targets undetermined
The identification of the binding site
Dependence on protein and ligand structures
Source (epo, co-crystal, complex of other inhibitor, NMR, homology), Treatment
(hydrogen atoms, optimization), Flexibility, Starting Conformation, Structural
Diversity, Protonated State
Similar ligands may unexpectedly bind in quite different modes
MJ33 in phospholipase A2 (Sekar et al. 1997); BANA113 in influenza virus
neuraminidase (Sudbeck et al. 1997).
Favor larger & more complicated molecules
But contributions to binding free energy from the heavy atoms of the ligand level
off at ~15 atoms. Many interactions, including H-bonding, do not always lead to
higher binding affinity (Kuntz et al. 1999).
September 21, 2004
Copyright 2004 Eli Lilly and Company 46
Challenges to Docking Approach
Large energies vs. small energy differences
Find weakly potent compounds in pools of nonbinders
High false positives and false negatives from in silico screen
Explicit water are needed for: volume, change shape of the binding
site, bridging interaction
A scoring function that always has its global optimum in agreement
with the experiment.
Good affinity prediction not necessarily leads to correct binding mode
Speed and accuracy
September 21, 2004
Copyright 2004 Eli Lilly and Company 47
Successes of Docking & SBDD
HIV protease inhibitor amprenavir (Agenerase) from Vertex &
GSK (Kim et al. 1995)
HIV: nelfinavir (Viracept) by Pfizer (& Agouron) (Greer et al.
1994)
Influenza neuraminidase inhibitor zanamivir (Relenza) by GSK
(Schindler 2000)
Widely used & greatly appreciated. Identified many hits.
Review articles by Kuntz 1992; Kuntz et al. 1994; Kubinyi 1998; Muegge
& Rarey 2001; Blundell 2002; Halperin et al. 2002; Shoichet et al. 2002;
Taylor et al. 2002; Waszkowycz 2002; Davis et al. 2003; Schneidman-
duhovny et al. 2004.

Anda mungkin juga menyukai